Joel Greenblatt Harmony Biosciences Holdings, Inc. Transaction History
Gotham Asset Management, LLC
- $6.49 Billion
- Q1 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 83,728 shares of HRMY stock, worth $2.72 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
83,728
Previous 82,198
1.86%
Holding current value
$2.72 Million
Previous $2.65 Million
5.92%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$365 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$118 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$84.8 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$81.2 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.93B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...